NurExone Biologic’s $2m Private Placement

Georgio Naffaa
Tagged:

Gowling WLG advised NurExone on the private placement.NurExone Biologic Inc., a biopharmaceutical company pioneering the development of non-invasive ExoTherapy for treating traumatic spinal cord injuries, announced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Georgio Naffaa

…

This content is for Standard 1 Year members only.
Login Join Now